GE HealthCare Technologies Inc. (GEHC) shareholders
Close on Nov 17, 2026Market cap $37.00BP/E 17.3Yield 0.17%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Dodge & Cox | 37,864,164 | 8.30% | 13G (passive) amendment | Jun 30, 2026 |
| BlackRock, Inc. | 36,271,390 | 7.90% | 13G (passive) amendment | Sep 30, 2024 |
| Vanguard Capital Management | 33,370,111 | 7.31% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of GEHC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Dodge & Cox | 37,864,164 | 8.37% | $2.42B | +6,552,100 | 1.27% |
| BlackRock, Inc. | 37,467,843 | 8.29% | $2.40B | +1,483,516 | 0.04% |
| Vanguard Capital Management LLC | 29,724,359 | 6.57% | $1.90B | +860,171 | 0.04% |
| State Street Corp | 20,861,566 | 4.61% | $1.34B | +323,090 | 0.04% |
| Vanguard Portfolio Management LLC | 20,275,526 | 4.48% | $1.30B | +1,092,369 | 0.06% |
| Invesco Ltd. | 18,296,350 | 4.05% | $1.17B | +992,911 | 0.09% |
| Harris Associates L P | 15,329,664 | 3.39% | $981.25M | −265,324 | 1.30% |
| Barrow Hanley Mewhinney & Strauss LLC | 13,455,814 | 2.98% | $861.31M | +1,571,226 | 2.61% |
| Geode Capital Management, LLC | 12,871,800 | 2.85% | $820.82M | +472,165 | 0.04% |
| Hotchkis & Wiley Capital Management LLC | 12,250,502 | 2.71% | $784.15M | +2,282,629 | 2.29% |
| JPMorgan Chase & Co | 10,329,164 | 2.28% | $671.91M | +1,364,495 | 0.04% |
| Morgan Stanley | 6,223,322 | 1.38% | $398.36M | −417,801 | 0.02% |
| Norges Bank | 5,823,524 | 1.29% | $372.76M | New | 0.04% |
| Dimensional Fund Advisors LP | 5,401,410 | 1.19% | $345.79M | +1,971 | 0.06% |
| Boston Partners | 5,153,347 | 1.14% | $329.83M | +55,647 | 0.29% |
| Van Eck Associates Corp | 4,482,631 | 0.99% | $286.93M | +177,028 | 0.17% |
| Goldman Sachs Group Inc | 4,446,565 | 0.98% | $284.62M | +1,180,427 | 0.02% |
| Northern Trust Corp | 3,938,748 | 0.87% | $252.12M | −113,317 | 0.03% |
| Lsv Asset Management | 3,482,902 | 0.77% | $222.94M | +1,666,732 | 0.40% |
| Bank Of America Corp /De/ | 3,249,771 | 0.72% | $208.02M | −882,969 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1,224 | 394M | 87.2% | 136 / 401 | 469 / 164 | 50M | 54M |
| Q1 2026 | 1,274 | 399M | 88.2% | 128 / 390 | 487 / 164 | 80M | 45M |
| Q4 2025 | 1,336 | 416M | 92.0% | 182 / 427 | 474 / 96 | 61M | 28M |
| Q3 2025 | 1,279 | 384M | 84.9% | 117 / 482 | 410 / 133 | 45M | 43M |
| Q2 2025 | 1,314 | 383M | 84.6% | 123 / 490 | 463 / 162 | 56M | 56M |
| Q1 2025 | 1,370 | 383M | 84.6% | 162 / 503 | 455 / 96 | 31M | 36M |
| Q4 2024 | 1,326 | 389M | 86.0% | 214 / 498 | 400 / 133 | 40M | 32M |
| Q3 2024 | 1,275 | 382M | 84.5% | 157 / 471 | 411 / 81 | 78M | 36M |
| Q2 2024 | 1,215 | 375M | 82.9% | 98 / 510 | 379 / 126 | 22M | 28M |
| Q1 2024 | 1,255 | 381M | 84.3% | 164 / 454 | 411 / 82 | 52M | 48M |
| Q4 2023 | 1,187 | 378M | 83.6% | 168 / 399 | 424 / 73 | 30M | 20M |
| Q3 2023 | 1,107 | 368M | 81.5% | 120 / 408 | 371 / 129 | 30M | 25M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
755 funds held GEHC in Q2 2026, 43% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of GEHC | Value | % of fund | As of |
|---|---|---|---|---|---|
| Dodge & Cox Stock Fund | 24,107,613 | 5.33% | $1.54B | 1.30% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 14,443,072 | 3.19% | $924.50M | 0.04% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 11,786,376 | 2.61% | $754.45M | 0.05% | Jun 30, 2026 |
| Vanguard Windsor Ii Fund | 10,850,329 | 2.40% | $738.04M | 1.10% | Jul 31, 2026 |
| Vanguard Mid-Cap Index Fund | 9,856,342 | 2.18% | $630.90M | 0.28% | Jun 30, 2026 |
| Invesco QQQ Trust, Series 1 | 9,656,078 | 2.14% | $618.09M | 0.13% | Jun 30, 2026 |
| iShares Core S&P 500 ETF | 6,256,637 | 1.38% | $400.49M | 0.05% | Jun 30, 2026 |
| Oakmark Fund | 5,954,000 | 1.32% | $381.12M | 1.59% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 5,832,244 | 1.29% | $363.58M | 0.04% | May 31, 2026 |
| Vanguard Value Index Fund | 4,326,933 | 0.96% | $276.97M | 0.11% | Jun 30, 2026 |
| VanEck Morningstar Wide Moat ETF | 4,021,566 | 0.89% | $257.42M | 2.21% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 3,213,607 | 0.71% | $205.70M | 0.51% | Jun 30, 2026 |
| Invesco S&P 500 Equal Weight ETF | 2,922,407 | 0.65% | $198.78M | 0.21% | Jul 31, 2026 |
| Vanguard Mid-Cap Value Index Fund | 2,921,698 | 0.65% | $187.02M | 0.50% | Jun 30, 2026 |
| Bridge Builder Large Cap Value Fund | 2,666,781 | 0.59% | $170.70M | 0.59% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Peter J. Arduini | President and CEO, Director | 241,606 | 0.05% | Sep 4, 2026 |
| William K. Grogan | Chief Financial Officer | 75,096 | 0.02% | Sep 16, 2026 |
| Adam Y. Holton | Chief People Officer | 19,533 | 0.00% | Sep 4, 2026 |
| Taha Kass-Hout | Chief Technology Officer | 88,467 | 0.02% | Sep 4, 2026 |
| Philip Rackliffe | CEO, AIS | 41,533 | 0.01% | Sep 4, 2026 |
| George A. Newcomb | Chief Accounting Officer | 10,527 | 0.00% | Sep 4, 2026 |
| Frank R. Jimenez | GC & Corporate Secretary | 89,321 | 0.02% | Sep 4, 2026 |
| Catherine Estrampes | Chief Commer. & Growth Officer | 23,573 | 0.01% | Sep 4, 2026 |
| Kevin Michael O'Neill | CEO, PDx | 32,085 | 0.01% | Sep 4, 2026 |
| Jeannette Bankes | CEO, Patient Care Solutions | 37,293 | 0.01% | Sep 3, 2026 |
| James Saccaro | Chief Financial Officer | 87,471 | 0.02% | May 1, 2026 |
| Roland Rott | CEO, Imaging | 41,082 | 0.01% | Mar 4, 2026 |
| Kenneth R. Stacherski | Chief Enterprise Oper. Officer | 40,996 | 0.01% | Sep 3, 2025 |
| Thomas J. Westrick | CEO, Patient Care Solutions | 18,501 | 0.00% | Mar 5, 2025 |
| Kevin Lobo | Director | 14,363 | 0.00% | May 26, 2026 |
| Rodney F. Hochman | Director | 21,504 | 0.00% | May 13, 2026 |
| H. Lawrence Culp Jr | Director | 499,917 | 0.11% | May 11, 2026 |
| Watkin Phoebe L. Yang | Director | 13,702 | 0.00% | May 11, 2026 |
| Catherine A. Lesjak | Director | 12,702 | 0.00% | May 11, 2026 |
| William J. Stromberg | Director | 18,916 | 0.00% | May 11, 2026 |
| Anne T. Madden | Director | 19,479 | 0.00% | May 11, 2026 |
| Tomislav Mihaljevic | Director | 9,116 | 0.00% | May 30, 2025 |
| Lloyd Howell Jr | Director | 9,116 | 0.00% | May 30, 2025 |
| Risa J. Lavizzo-Mourey | Director | 10,157 | 0.00% | May 30, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| William K. Grogan Chief Financial Officer | Sep 14, 2026 | Award | +12,840 | – | – | 75,096 |
| William K. Grogan Chief Financial Officer | Sep 14, 2026 | Award | +62,256 | – | – | 62,256 |
| Adam Y. Holton Chief People Officer | Sep 3, 2026 | Tax withholding | −673 | $70.56 | $47.49K | 19,533 |
| George A. Newcomb Chief Accounting Officer | Sep 3, 2026 | Tax withholding | −112 | $70.56 | $7.90K | 10,515 |
| Kevin Michael O'Neill CEO, PDx | Sep 3, 2026 | Tax withholding | −718 | $70.56 | $50.66K | 32,026 |
| Catherine Estrampes Chief Commer. & Growth Officer | Sep 3, 2026 | Tax withholding | −508 | $70.56 | $35.84K | 23,573 |
| Peter J. Arduini President and CEO, Director | Sep 3, 2026 | Tax withholding | −6,303 | $70.56 | $444.74K | 241,606 |
| Philip Rackliffe CEO, AIS | Sep 3, 2026 | Tax withholding | −798 | $70.56 | $56.31K | 41,533 |
| Taha Kass-Hout Chief Technology Officer | Sep 3, 2026 | Tax withholding | −1,502 | $70.56 | $105.98K | 88,467 |
| Frank R. Jimenez GC & Corporate Secretary | Sep 3, 2026 | Tax withholding | −1,480 | $70.56 | $104.43K | 89,321 |
| Adam Y. Holton Chief People Officer | Sep 1, 2026 | Tax withholding | −659 | $71.23 | $46.94K | 20,206 |
| Peter J. Arduini President and CEO, Director | Sep 1, 2026 | Tax withholding | −5,472 | $71.23 | $389.77K | 247,909 |
| Peter J. Arduini President and CEO, Director | Sep 1, 2026 | Tax withholding | −6,043 | $71.23 | $430.44K | 253,381 |
| Frank R. Jimenez GC & Corporate Secretary | Sep 1, 2026 | Tax withholding | −1,751 | $71.23 | $124.72K | 92,181 |
| Frank R. Jimenez GC & Corporate Secretary | Sep 1, 2026 | Tax withholding | −1,380 | $71.23 | $98.30K | 90,801 |
| Jeannette Bankes CEO, Patient Care Solutions | Sep 1, 2026 | Tax withholding | −1,064 | $71.23 | $75.79K | 37,293 |
| Taha Kass-Hout Chief Technology Officer | Sep 1, 2026 | Tax withholding | −1,644 | $71.23 | $117.10K | 91,265 |
| Taha Kass-Hout Chief Technology Officer | Sep 1, 2026 | Tax withholding | −1,296 | $71.23 | $92.31K | 89,969 |
| Philip Rackliffe CEO, AIS | Sep 1, 2026 | Tax withholding | −290 | $71.23 | $20.66K | 42,897 |
| Philip Rackliffe CEO, AIS | Sep 1, 2026 | Tax withholding | −340 | $71.23 | $24.22K | 42,331 |
| Philip Rackliffe CEO, AIS | Sep 1, 2026 | Tax withholding | −226 | $71.23 | $16.10K | 42,671 |
| Adam Y. Holton Chief People Officer | Aug 15, 2026 | Tax withholding | −1,360 | $73.69 | $100.22K | 20,865 |
| Kevin Lobo Director | May 22, 2026 | Buy | +10,000 | $64.18 | $641.80K | 14,363 |
| Jeannette Bankes CEO, Patient Care Solutions | May 15, 2026 | Tax withholding | −5,535 | $62.67 | $346.88K | 38,357 |
| Philip Rackliffe CEO, AIS | May 15, 2026 | Award | +16,458 | – | – | 43,187 |
| Rodney F. Hochman Director | May 12, 2026 | Buy | +1,618 | $62.03 | $100.36K | 1,618 |
| Watkin Phoebe L. Yang Director | May 8, 2026 | Buy | +1,000 | $63.01 | $63.01K | 13,702 |
| Catherine A. Lesjak Director | May 7, 2026 | Award | +3,586 | – | – | 12,702 |
| Watkin Phoebe L. Yang Director | May 7, 2026 | Award | +3,586 | – | – | 12,702 |
| William J. Stromberg Director | May 7, 2026 | Award | +3,586 | – | – | 18,916 |
| H. Lawrence Culp Jr Director | May 7, 2026 | Award | +4,157 | – | – | 20,442 |
| H. Lawrence Culp Jr Director | May 7, 2026 | Award | +3,586 | – | – | 16,285 |
| Anne T. Madden Director | May 7, 2026 | Award | +2,282 | – | – | 19,479 |
| Anne T. Madden Director | May 7, 2026 | Award | +3,586 | – | – | 17,197 |
| Rodney F. Hochman Director | May 7, 2026 | Award | +2,689 | – | – | 19,886 |
| Rodney F. Hochman Director | May 7, 2026 | Award | +3,586 | – | – | 17,197 |
| Kevin Lobo Director | May 7, 2026 | Award | +3,586 | – | – | 4,363 |
| William J. Stromberg Director | May 6, 2026 | Buy | +1,000 | $61.69 | $61.69K | 15,330 |
| H. Lawrence Culp Jr Director | May 6, 2026 | Buy | +80,805 | $61.88 | $5.00M | 151,207 |
| James Saccaro Chief Financial Officer | May 1, 2026 | Buy | +3,310 | $60.60 | $200.59K | 87,471 |
| Frank R. Jimenez GC & Corporate Secretary | Apr 30, 2026 | Buy | +1,750 | $60.45 | $105.79K | 93,932 |
| Peter J. Arduini President and CEO, Director | Apr 30, 2026 | Buy | +4,169 | $59.93 | $249.85K | 259,424 |
| Kevin Lobo Director | Mar 13, 2026 | Award | +777 | – | – | 777 |
| Roland Rott CEO, Imaging | Mar 2, 2026 | Award | +8,576 | – | – | 41,082 |
| James Saccaro Chief Financial Officer | Mar 2, 2026 | Award | +12,475 | – | – | 84,161 |
| Taha Kass-Hout Chief Technology Officer | Mar 2, 2026 | Award | +13,254 | – | – | 92,909 |
| Peter J. Arduini President and CEO, Director | Mar 2, 2026 | Award | +49,120 | – | – | 255,255 |
| Jeannette Bankes CEO, Patient Care Solutions | Mar 2, 2026 | Award | +6,861 | – | – | 43,892 |
| Frank R. Jimenez GC & Corporate Secretary | Mar 2, 2026 | Award | +10,915 | – | – | 92,182 |
| Philip Rackliffe CEO, AVS | Mar 2, 2026 | Award | +9,356 | – | – | 26,729 |
| Adam Y. Holton Chief People Officer | Mar 2, 2026 | Award | +5,457 | – | – | 22,225 |
| Kevin Michael O'Neill CEO, PDx | Mar 2, 2026 | Award | +6,549 | – | – | 32,744 |
| George A. Newcomb Chief Accounting Officer | Mar 2, 2026 | Award | +1,309 | – | – | 10,627 |
| Frank R. Jimenez GC & Corporate Secretary | Feb 12, 2026 | Tax withholding | −8,357 | $79.20 | $661.87K | 81,267 |
| Frank R. Jimenez GC & Corporate Secretary | Feb 12, 2026 | Award | +22,078 | – | – | 89,624 |
| Philip Rackliffe CEO, AVS | Feb 12, 2026 | Tax withholding | −1,174 | $79.20 | $92.98K | 17,373 |
| Philip Rackliffe CEO, AVS | Feb 12, 2026 | Award | +3,154 | – | – | 18,547 |
| George A. Newcomb Chief Accounting Officer | Feb 12, 2026 | Award | +2,523 | – | – | 10,120 |
| George A. Newcomb Chief Accounting Officer | Feb 12, 2026 | Tax withholding | −802 | $79.20 | $63.52K | 9,318 |
| Taha Kass-Hout Chief Technology Officer | Feb 12, 2026 | Award | +23,339 | – | – | 87,442 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of GE HealthCare Technologies's stock actually held short. Settlement fails (shares not delivered on time) peaked at 42,903 shares on Oct 13, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| James Saccaro Former Officer | Nov 4, 2026 | 78,348 | $6.73M | Nov 4, 2026 | Stock Option Exercise |
| Kenneth R. Stacherski Former Officer | Nov 24, 2025 | 4,585 | $353.05K | Nov 24, 2025 | Stock Option Exercise |
| Kenneth R. Stacherski Former Officer | Oct 27, 2025 | 4,585 | $361.99K | Oct 27, 2025 | Stock Option Exercise |
| Kenneth R. Stacherski Former Officer | Sep 22, 2025 | 19,524 | $1.45M | Sep 22, 2025 | Restricted Stock Vest |
| Kenneth R. Stacherski Former Officer | Sep 12, 2025 | 11,757 | $905.59K | Sep 12, 2025 | Stock Option Exercise |
| Roland Rott Officer | Nov 6, 2024 | 3,577 | $309.33K | Nov 6, 2024 | Stock Option Exercise |
| Philip Rackliffe Officer | Nov 5, 2024 | 900 | $78.87K | Nov 5, 2024 | Restricted Stock Vest |
| Kenneth R. Stacherski Officer | Aug 14, 2024 | 19,008 | $1.57M | Aug 14, 2024 | Restricted Stock Vest |
| Jan Makela Officer | Aug 12, 2024 | 33,096 | $2.75M | Aug 12, 2024 | Stock Option Exercise |
| Thomas J. Westrick Officer | Aug 7, 2024 | 2,750 | $222.15K | Aug 7, 2024 | Restricted Stock Vest |
| Taha Kass-Hout Officer | May 28, 2024 | 3,300 | $259.72K | May 28, 2024 | Restricted Stock Vest |
| Betty D. Larson Officer | May 17, 2024 | 13,588 | $1.11M | May 17, 2024 | Restricted Stock Vest |
| Jan Makela Officer | May 13, 2024 | 87,182 | $7.11M | May 13, 2024 | Stock Option Exercise |
| Kevin Michael O'Neill Officer | Jul 31, 2023 | 15,609 | $1.21M | Jul 31, 2023 | Stock and Option Vesting |
| Roland Rott Officer | Jun 8, 2023 | 2,473 | $191.34K | Jun 8, 2023 | Restricted Stock Vesting |
Congress trades
11 trades in GE HealthCare Technologies reported by 5 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Rohit Khanna CA17 · child | Bought | Jul 30, 2026 | $1K–15K | Aug 7, 2026 |
| Rohit Khanna CA17 · child | Bought | Jul 6, 2026 | $1K–15K | Aug 7, 2026 |
| Rohit Khanna CA17 · child | Bought | Jul 2, 2026 | $1K–15K | Aug 7, 2026 |
| Terri A. Sewell AL07 | Sold | Mar 25, 2026 | $1K–15K | Apr 21, 2026 |
| Warren Davidson OH08 | Sold | Mar 23, 2026 | $1K–15K | Mar 25, 2026 |
| Rob Bresnahan PA08 | Bought | May 15, 2025 | $1K–15K | May 31, 2025 |
| Rob Bresnahan PA08 | Sold | Apr 8, 2025 | $1K–15K | Apr 28, 2025 |
| Austin Scott GA08 · spouse | Sold | Mar 27, 2025 | $1K–15K | Aug 13, 2025 139 days late |
| Rob Bresnahan PA08 | Bought | Feb 25, 2025 | $1K–15K | Mar 27, 2025 |
| Rohit Khanna CA17 · child | Bought | Jan 13, 2023 | $1K–15K | Feb 7, 2023 |
| Austin Scott GA08 · spouse | Exchanged | Jan 4, 2023 | $1K–15K | Jan 23, 2023 |
See a number that looks wrong?